查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1469267

全球骨科規劃系統市場：依產品類型、最終用戶、地區：產業分析、規模、佔有率、成長、趨勢、預測（2024-2031）

Orthopedic Planning Systems Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 380 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究提供了一份全面的報告，全面分析了骨科規劃系統市場並詳細介紹了其全球前景。這份詳細的出版物提供了有關市場動態、趨勢、機會和課題的寶貴見解，並對其結構進行了全面概述。在獨特的數據和統計數據的支持下，本研究預測了 2024 年至 2031 年骨科規劃系統市場的預期成長軌跡。

2024年，骨科規劃系統的全球收入預計將達到8,615萬美元，複合年增長率為7.9%，2031年將達到1.582億美元。

重要見解

  • 骨科規劃系統市場規模（2024年）：8,615萬美元
  • 預計市場價值（2031 年）：1.582 億美元
  • 全球市場成長率（2024-2032年複合年增長率）：7.9%

骨科規劃系統市場-調查範圍

全球整形外科規劃系統市場為整形外科醫生和醫療保健提供者提供了各種解決方案，以促進手術規劃和植入物選擇。主要驅動因素包括醫療技術的進步、骨科疾病盛行率的增加以及人口老化。新興趨勢包括個人化醫療和 3D 列印應用。總體而言，對高效外科手術、改善患者治療效果以及對具有成本效益的醫療保健解決方案的需求不斷增長正在推動市場發展。

市場驅動因素

骨科規劃系統的日益普及是由幾個相互關聯的因素推動的，包括技術創新和對微創手術技術的接受度不斷提高。影像模式和電腦輔助手術的進步正在提高手術精確度和病患安全，推動對骨科規劃解決方案的需求。此外，人口老化和肥胖率上升等人口變化也導致骨科疾病盛行率上升，推動市場成長。隨著醫療保健提供者努力優化治療結果並儘量減少併發症，骨科規劃系統在簡化手術程序和加強患者護理方面發揮關鍵作用。

市場製約因素

骨科規劃系統市場面臨的課題包括監管障礙、報銷限制和資料安全問題。遵守醫療設備和軟體的嚴格監管要求給市場參與者帶來了課題，需要在研發和監管合規方面進行大量投資。此外，報銷政策因地區而異，影響骨科治療計劃系統的實施和提供者的決策。對資料安全和病患隱私的擔憂也是市場成長的障礙，需要採取強有力的網路安全措施並遵守資料保護法規來保護病患資訊。

市場機會

骨科規劃系統領域的市場成長機會包括新興市場的應用擴展、技術進步和策略夥伴關係。新興國家骨科疾病盛行率的上升、醫療基礎設施的改善以及先進醫療技術的普及創造了市場擴張的機會。此外，3D 列印和人工智慧領域的持續創新為增強骨科規劃系統的功能提供了機會，從而實現個人化治療方法和優化手術結果。骨科設備製造商、軟體開發商和醫療保健組織之間的合作促進了整合解決方案的開發，以滿足骨科醫生和患者不斷變化的需求。

報告回答的關鍵問題

  • 推動骨科規劃系統市場成長的關鍵因素是什麼？
  • 塑造骨科規劃系統市場的新興趨勢是什麼？
  • 阻礙市場擴張的主要課題是什麼？
  • 骨科規劃系統領域的市場參與者有哪些機會？

目錄

第一章內容提要

第二章市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包容與排除

第 3 章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第四章市場背景

  • 宏觀經濟因素
  • 預測器
  • 市場動態
  • 全球供需分析

第五章 新冠疫情危機分析

  • 目前的 COVID19 統計數據和未來潛在的影響
  • COVID19 與影響分析
    • 依溶液
    • 依用途
    • 展開類別
    • 依最終用戶

第 6 章關鍵成功因素

  • 重大發展
  • 監管場景
  • 主要交易及合約
  • 依地區劃分的手術數量

第七章全球骨科規劃系統市場：價格分析

  • 依國家和地區劃分的定價分析（依解決方案）
  • 價格細目
    • 製造商級定價
    • 經銷商級定價
  • 全球平均價格分析基準

第八章全球骨科規劃系統市場需求分析（2019-2023）與預測（2024-2031）

  • 2019-2023年歷史市值分析
  • 當前和未來市場價值預測，2024-2031
    • 同比增長趨勢分析
    • 絕對獲利機會分析

第9章全球骨科規劃系統市場分析（2019-2023）與預測（2024-2031）（依解法）

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模分析（依解決方案）
  • 當前和未來的市場規模分析和預測（依解決方案），2024-2031 年
    • 骨科手術計劃系統
      • 術前規劃軟體
        • 2D規劃軟體
        • 3D規劃軟體
      • 術後規劃軟體
  • 依解決方案進行市場吸引力分析

第10章全球骨科規劃系統市場分析（2019-2023）與預測（2024-2031）（依應用）

  • 簡介/主要發現
  • 過去的市場規模分析（依應用），2019-2023
  • 2024-2031 年當前和未來市場規模（依應用）分析和預測
    • 骨科
      • 關節置換手術
        • 髖關節置換術
        • 膝關節置換術
        • 肩關節置換術
        • 聽骨置換
    • 骨科腫瘤學
  • 依應用劃分的市場吸引力分析

第十一章全球骨科規劃系統市場分析（2019-2023）與預測（2024-2031）（依發展）

  • 簡介/主要發現
  • 過去的市場規模分析（依發展），2019-2023
  • 2024-2031 年當前和未來市場規模（依發展情況）分析和預測
    • 網路為基礎的軟體
    • 基於雲的軟件
    • 本地
  • 依發展劃分的市場吸引力分析

第十二章全球骨科規劃系統市場分析（2019-2023）與預測（2024-2031）（依最終使用者）

  • 簡介/主要發現
  • 2019-2023 年歷史市場規模分析（依最終用戶）
  • 2024-2031 年最終用戶當前和未來市場規模的分析和預測
    • 醫院
    • 門診手術中心
    • 骨科診所基地
    • 診所
  • 依最終用戶劃分的市場吸引力分析

第十三章依地區分列的全球骨科規劃系統市場分析（2019-2023）和預測（2024-2031）

  • 介紹
  • 2019-2023 年歷史市場規模分析（依地區）
  • 當前市場規模分析和預測（依地區），2024-2031
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲 (MEA)
  • 依地區劃分的市場吸引力分析

第14章北美骨科規劃系統市場分析（2019-2023）與預測（2024-2031）

第十五章拉丁美洲骨科規劃系統市場分析（2019-2023）與預測（2024-2031）

第十六章歐洲骨科規劃系統市場分析（2019-2023）與預測（2024-2031）

第十七章南亞和太平洋地區骨科規劃系統市場分析（2019-2023）和預測（2024-2031）

第十八章東亞骨科規劃系統市場分析（2019-2023）與預測（2024-2031）

第十九章大洋洲骨科規劃系統市場分析（2019-2023）與預測（2024-2031）

第20章中東和非洲骨科規劃系統市場分析（2019-2023）和預測（2024-2031）

第21章主要全國骨科規劃系統市場分析（2024-2031）

  • 介紹
    • 市值比率分析
    • 全球和國家成長比較
    • 依國家/地區的價格分析
  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 德國
  • 義大利
  • 法國
  • 英國
  • 西班牙
  • 俄羅斯
  • 中國
  • 日本
  • 韓國
  • 印度
  • 東盟
  • 澳大利亞
  • 紐西蘭
  • 土耳其
  • 南非

第22章市場結構分析

  • 市場分析：依公司層級（骨科手術規劃系統）
  • 主要參與者的市場佔有率分析
  • 市場存在分析

第 23 章 競爭分析

  • 比賽儀表板
  • 競爭標桿
  • 競爭對手詳情
    • Formus Labs Ltd
    • EOS imaging
    • Brainlab AG
    • Sectra AB
    • Stryker
    • Materialise
    • Medstrat
    • MediCAD Hectec GmbH
    • 3D Systems, Inc
    • PEEK HEALTH SA
    • Radlink, Inc.
    • SurgiNovi
    • RSA Biomedical
    • HIPOP-PLAN
    • Zimmer Biomet.
    • Optinav
    • Enhatch Inc.
    • Numex GmbH
    • Corin Group

第 24 章先決條件和使用的縮寫詞

第25章研究方法論

簡介目錄
Product Code: PMRREP26182

Persistence Market Research has conducted a thorough analysis of the Orthopedic Planning Systems Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Orthopedic Planning Systems Market spanning from 2024 to 2031.

In 2024, global revenue from orthopedic planning systems reached US$ 86.15 million, projected to grow at a CAGR of 7.9%, reaching US$ 158.2 million by 2031.

Key Insights:

  • Orthopedic Planning Systems Market Size (2024): US$ 86.15 Mn
  • Projected Market Value (2031): US$ 158.2 Mn
  • Global Market Growth Rate (2024-2031): 7.9% CAGR

Orthopedic Planning Systems Market - Report Scope

The global orthopedic planning systems market offers various solutions for orthopedic surgeons and healthcare providers, facilitating surgical planning and implant selection. Key drivers include advancements in medical technology, increasing prevalence of orthopedic disorders, and the growing aging population. Emerging trends focus on personalized medicine and 3D printing applications. Overall, the market is driven by the rising demand for efficient surgical procedures, improved patient outcomes, and the need for cost-effective healthcare solutions.

Market Growth Drivers

The expanding adoption of orthopedic planning systems is fueled by several interconnected factors, including technological innovation and the growing acceptance of minimally invasive surgical techniques. Advances in imaging modalities and computer-assisted surgery enhance surgical accuracy and patient safety, driving the demand for orthopedic planning solutions. Additionally, demographic shifts, such as an aging population and rising obesity rates, contribute to the increasing incidence of orthopedic conditions, boosting market growth. As healthcare providers strive to optimize treatment outcomes and minimize complications, orthopedic planning systems play a crucial role in streamlining surgical procedures and enhancing patient care.

Market Restraints

Challenges facing the orthopedic planning systems market include regulatory hurdles, reimbursement limitations, and data security concerns. Compliance with stringent regulatory requirements for medical devices and software poses challenges for market players, necessitating substantial investments in research and development and regulatory compliance efforts. Moreover, reimbursement policies vary across regions, impacting the adoption of orthopedic planning systems and healthcare provider decisions. Data security and patient privacy concerns also present barriers to market growth, requiring robust cybersecurity measures and compliance with data protection regulations to safeguard patient information.

Opportunities

Opportunities for market growth in the orthopedic planning systems segment include expanding applications in emerging markets, technological advancements, and strategic partnerships. The rising prevalence of orthopedic disorders in developing countries creates opportunities for market expansion, as healthcare infrastructure improves and access to advanced medical technologies increases. Furthermore, ongoing innovations in 3D printing and artificial intelligence offer opportunities to enhance the capabilities of orthopedic planning systems, enabling personalized treatment approaches and optimizing surgical outcomes. Collaborations between orthopedic device manufacturers, software developers, and healthcare institutions facilitate the development of integrated solutions that address the evolving needs of orthopedic surgeons and patients.

Key Questions Answered in Report::

  • What are the key drivers propelling the growth of the orthopedic planning systems market?
  • What emerging trends are shaping the landscape of orthopedic planning systems?
  • What are the primary challenges hindering market expansion, and how can they be mitigated?
  • What opportunities exist for market players to capitalize on in the orthopedic planning systems segment?

Competitive Intelligence and Business Strategy

In October 2020, EOS imaging installed its first EOSedge(TM) system at the Macquarie University Hospital in Australia, marking a significant milestone for the company in expanding its market presence.

In December 2020, Zimmer Biomet bolstered its product offerings by acquiring A&E Medical, gaining access to a diverse portfolio of sternal closure devices, including cable systems and sternal sutures.

In April 2020, Brainlab achieved CE Mark approval for its advanced patient positioning and monitoring system, ExacTrac(R) Dynamic, demonstrating its commitment to innovation and meeting regulatory standards.

Key Companies Profiled

  • Formus Labs Ltd,
  • EOS imaging,
  • Brainlab AG,
  • Sectra AB,
  • Stryker,
  • Materialise,
  • Medstrat,
  • mediCAD Hectec GmbH,
  • 3D Systems, Inc.,
  • PEEK HEALTH S.A,
  • Radlink, Inc.,
  • SurgiNovi,
  • RSA Biomedical,
  • HIPOP-PLAN,
  • Zimmer Biomet,
  • Optinav,
  • Enhatch Inc.,

Key Segments Covered in Orthopedic Planning Systems Industry Research

Orthopedic Planning Systems Market by Solution:

  • Pre-Surgical Planning Software

o2D Planning Software

o3D Planning Software

  • Post-Surgical Planning Software

Orthopedic Planning Systems Market by Application:

  • Joint Replacement

oHip Replacement

oKnee Replacement

oShoulder Replacement

oSmall Bone Replacement

  • Orthopaedic Oncology

Orthopedic Planning Systems Market by Deployment:

  • Web Based Software
  • Cloud Based Software
  • On Premises

Orthopedic Planning Systems Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopaedic Office-Based Clinics

Orthopedic Planning Systems Market by Region:

  • North America Orthopedic Planning Systems Market
  • Latin America Orthopedic Planning Systems Market
  • Europe Orthopedic Planning Systems Market
  • South Asia Orthopedic Planning Systems Market
  • East Asia Orthopedic Planning Systems Market
  • Oceania Orthopedic Planning Systems Market
  • Middle East & Africa Orthopedic Planning Systems Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Market Background

  • 4.1. Macro-Economic factors
    • 4.1.1. Global Healthcare Market Outlook
    • 4.1.2. Healthcare IT Spending Outlook, By U.S. & Global
    • 4.1.3. U.S. per-Capita Healthcare Expenditure
  • 4.2. Forecast Factors
    • 4.2.1. Evaluation of Incremental Costs and Effectiveness
    • 4.2.2. Increasing Spending on Healthcare Per Capita
    • 4.2.3. Increasing Spending for Healthcare Infrastructure Development Post COVID-19 Pandemic
    • 4.2.4. Application of biomedical and nanotechnology in Orthopaedics
  • 4.3. Market Dynamics
    • 4.3.1. Demand
    • 4.3.2. Restraints
    • 4.3.3. Opportunity
  • 4.4. Global Supply Demand Analysis

5. COVID19 Crisis Analysis

  • 5.1. Current COVID19 Statistics and Probable Future Impact
  • 5.2. COVID19 and Impact Analysis
    • 5.2.1. By Solution
    • 5.2.2. By Application
    • 5.2.3. By Deployment
    • 5.2.4. By End User

6. Key Success Factors

  • 6.1. Key Developments
  • 6.2. Regulatory Scenario
  • 6.3. Key Deals and Contracts
  • 6.4. Number of Surgeries, By Region

7. Global Orthopedic Planning Systems Market - Pricing Analysis

  • 7.1. Country-wise & Regional Pricing Analysis, By Solution
  • 7.2. Pricing Break-up
    • 7.2.1. Manufacturer Level Pricing
    • 7.2.2. Distributor Level Pricing
  • 7.3. Global Average Pricing Analysis Benchmark

8. Global Orthopedic Planning Systems Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 8.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis

9. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Solution

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Solution, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Solution, 2024-2031
    • 9.3.1. Orthopedic Planning Systems
      • 9.3.1.1. Pre-Surgical Planning Software
        • 9.3.1.1.1. 2D Planning Software
        • 9.3.1.1.2. 3D Planning Software
      • 9.3.1.2. Post-Surgical Planning Software
  • 9.4. Market Attractiveness Analysis, By Solution

10. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 10.3.1. Orthopedic Surgery
      • 10.3.1.1. Joint Replacement
        • 10.3.1.1.1. Hip Replacement
        • 10.3.1.1.2. Knee Replacement
        • 10.3.1.1.3. Shoulder Replacement
        • 10.3.1.1.4. Small Bone Replacement
    • 10.3.2. Orthopedic Oncology
  • 10.4. Market Attractiveness Analysis, By Application

11. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Deployment

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Deployment, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Deployment, 2024-2031
    • 11.3.1. Web Based Software
    • 11.3.2. Cloud Based Software
    • 11.3.3. On Premises
  • 11.4. Market Attractiveness Analysis, By Deployment

12. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centres
    • 12.3.3. Orthopedic Office-Based
    • 12.3.4. Clinics
  • 12.4. Market Attractiveness Analysis, By End User

13. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis, By Region

14. North America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Solution
    • 14.4.3. By Application
    • 14.4.4. By Deployment
    • 14.4.5. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Solution
    • 14.5.3. By Application
    • 14.5.4. By Deployment
    • 14.5.5. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Latin America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Mexico
      • 15.4.1.3. Rest of Latin America
    • 15.4.2. By Solution
    • 15.4.3. By Application
    • 15.4.4. By Deployment
    • 15.4.5. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Solution
    • 15.5.3. By Application
    • 15.5.4. By Deployment
    • 15.5.5. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Europe Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. Italy
      • 16.4.1.3. France
      • 16.4.1.4. U.K.
      • 16.4.1.5. Spain
      • 16.4.1.6. BENELUX
      • 16.4.1.7. Russia
      • 16.4.1.8. Rest of Europe
    • 16.4.2. By Solution
    • 16.4.3. By Application
    • 16.4.4. By Deployment
    • 16.4.5. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Solution
    • 16.5.3. By Application
    • 16.5.4. By Deployment
    • 16.5.5. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. South Asia and Pacific Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. ASEAN
      • 17.4.1.3. Oceania
      • 17.4.1.4. Rest of South Asia & Pacific
    • 17.4.2. By Solution
    • 17.4.3. By Application
    • 17.4.4. By Deployment
    • 17.4.5. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Solution
    • 17.5.3. By Application
    • 17.5.4. By Deployment
    • 17.5.5. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. East Asia Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Solution
    • 18.4.3. By Application
    • 18.4.4. By Deployment
    • 18.4.5. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Solution
    • 18.5.3. By Application
    • 18.5.4. By Deployment
    • 18.5.5. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Oceania Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 19.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Solution
    • 19.4.3. By Application
    • 19.4.4. By Deployment
    • 19.4.5. By End User
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Solution
    • 19.5.3. By Application
    • 19.5.4. By Deployment
    • 19.5.5. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 20.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Turkey
      • 20.4.1.3. Northern Africa
      • 20.4.1.4. South Africa
      • 20.4.1.5. Rest of Middle East and Africa
    • 20.4.2. By Solution
    • 20.4.3. By Application
    • 20.4.4. By Deployment
    • 20.4.5. By End User
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Solution
    • 20.5.3. By Application
    • 20.5.4. By Deployment
    • 20.5.5. By End User
  • 20.6. Market Trends
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Drivers and Restraints - Impact Analysis

21. Country Level Orthopedic Planning Systems Market Analysis 2024-2031

  • 21.1. Introduction
    • 21.1.1. Market Value Proportion Analysis
    • 21.1.2. Global VS. Country Growth Comparison
    • 21.1.3. Pricing Analysis, by Country
  • 21.2. U.S. Orthopedic Planning Systems Market Analysis
    • 21.2.1. By Solution
    • 21.2.2. By Application
    • 21.2.3. By Deployment
    • 21.2.4. By End User
  • 21.3. Canada Orthopedic Planning Systems Market Analysis
    • 21.3.1. By Solution
    • 21.3.2. By Application
    • 21.3.3. By Deployment
    • 21.3.4. By End User
  • 21.4. Mexico Orthopedic Planning Systems Market Analysis
    • 21.4.1. By Solution
    • 21.4.2. By Application
    • 21.4.3. By Deployment
    • 21.4.4. By End User
  • 21.5. Brazil Orthopedic Planning Systems Market Analysis
    • 21.5.1. By Solution
    • 21.5.2. By Application
    • 21.5.3. By Deployment
    • 21.5.4. By End User
  • 21.6. Germany Orthopedic Planning Systems Market Analysis
    • 21.6.1. By Solution
    • 21.6.2. By Application
    • 21.6.3. By Deployment
    • 21.6.4. By End User
  • 21.7. Italy Orthopedic Planning Systems Market Analysis
    • 21.7.1. By Solution
    • 21.7.2. By Application
    • 21.7.3. By Deployment
    • 21.7.4. By End User
  • 21.8. France Orthopedic Planning Systems Market Analysis
    • 21.8.1. By Solution
    • 21.8.2. By Application
    • 21.8.3. By Deployment
    • 21.8.4. By End User
  • 21.9. U.K. Orthopedic Planning Systems Market Analysis
    • 21.9.1. By Solution
    • 21.9.2. By Application
    • 21.9.3. By Deployment
    • 21.9.4. By End User
  • 21.10. Spain Orthopedic Planning Systems Market Analysis
    • 21.10.1. By Solution
    • 21.10.2. By Application
    • 21.10.3. By Deployment
    • 21.10.4. By End User
  • 21.11. Russia Orthopedic Planning Systems Market Analysis
    • 21.11.1. By Solution
    • 21.11.2. By Application
    • 21.11.3. By Deployment
    • 21.11.4. By End User
  • 21.12. China Orthopedic Planning Systems Market Analysis
    • 21.12.1. By Solution
    • 21.12.2. By Application
    • 21.12.3. By Deployment
    • 21.12.4. By End User
  • 21.13. Japan Orthopedic Planning Systems Market Analysis
    • 21.13.1. By Solution
    • 21.13.2. By Application
    • 21.13.3. By Deployment
    • 21.13.4. By End User
  • 21.14. S. Korea Orthopedic Planning Systems Market Analysis
    • 21.14.1. By Solution
    • 21.14.2. By Application
    • 21.14.3. By Deployment
    • 21.14.4. By End User
  • 21.15. India Orthopedic Planning Systems Market Analysis
    • 21.15.1. By Solution
    • 21.15.2. By Application
    • 21.15.3. By Deployment
    • 21.15.4. By End User
  • 21.16. ASEAN Orthopedic Planning Systems Market Analysis
    • 21.16.1. By Solution
    • 21.16.2. By Application
    • 21.16.3. By Deployment
    • 21.16.4. By End User
  • 21.17. Australia Orthopedic Planning Systems Market Analysis
    • 21.17.1. By Solution
    • 21.17.2. By Application
    • 21.17.3. By Deployment
    • 21.17.4. By End User
  • 21.18. New Zealand Orthopedic Planning Systems Market Analysis
    • 21.18.1. By Solution
    • 21.18.2. By Application
    • 21.18.3. By Deployment
    • 21.18.4. By End User
  • 21.19. Turkey Orthopedic Planning Systems Market Analysis
    • 21.19.1. By Solution
    • 21.19.2. By Application
    • 21.19.3. By Deployment
    • 21.19.4. By End User
  • 21.20. South Africa Orthopedic Planning Systems Market Analysis
    • 21.20.1. By Solution
    • 21.20.2. By Application
    • 21.20.3. By Deployment
    • 21.20.4. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis, By Tier of Companies (Orthopedic Planning Systems)
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis
    • 22.3.1. By Regional footprint of Players
    • 22.3.2. Device foot print by Players
    • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Benchmarking
  • 23.3. Competition Deep Dive
    • 23.3.1. Formus Labs Ltd
      • 23.3.1.1. Overview & Key financials
      • 23.3.1.2. Product Portfolio
      • 23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.1.4. SWOT Analysis
      • 23.3.1.5. Sales Footprint
      • 23.3.1.6. Strategy Overview
      • 23.3.1.7. Sales and Marketing strategies
      • 23.3.1.8. Channel Strategies
    • 23.3.2. EOS imaging
      • 23.3.2.1. Overview & Key financials
      • 23.3.2.2. Product Portfolio
      • 23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.2.4. SWOT Analysis
      • 23.3.2.5. Sales Footprint
      • 23.3.2.6. Strategy Overview
      • 23.3.2.7. Sales and Marketing strategies
      • 23.3.2.8. Channel Strategies
    • 23.3.3. Brainlab AG
      • 23.3.3.1. Overview & Key financials
      • 23.3.3.2. Product Portfolio
      • 23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.3.4. SWOT Analysis
      • 23.3.3.5. Sales Footprint
      • 23.3.3.6. Strategy Overview
      • 23.3.3.7. Sales and Marketing strategies
      • 23.3.3.8. Channel Strategies
    • 23.3.4. Sectra AB
      • 23.3.4.1. Overview & Key financials
      • 23.3.4.2. Product Portfolio
      • 23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.4.4. SWOT Analysis
      • 23.3.4.5. Sales Footprint
      • 23.3.4.6. Strategy Overview
      • 23.3.4.7. Sales and Marketing strategies
      • 23.3.4.8. Channel Strategies
    • 23.3.5. Stryker
      • 23.3.5.1. Overview & Key financials
      • 23.3.5.2. Product Portfolio
      • 23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.5.4. SWOT Analysis
      • 23.3.5.5. Sales Footprint
      • 23.3.5.6. Strategy Overview
      • 23.3.5.7. Sales and Marketing strategies
      • 23.3.5.8. Channel Strategies
    • 23.3.6. Materialise
      • 23.3.6.1. Overview & Key financials
      • 23.3.6.2. Product Portfolio
      • 23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.6.4. SWOT Analysis
      • 23.3.6.5. Sales Footprint
      • 23.3.6.6. Strategy Overview
      • 23.3.6.7. Sales and Marketing strategies
      • 23.3.6.8. Channel Strategies
    • 23.3.7. Medstrat
      • 23.3.7.1. Overview & Key financials
      • 23.3.7.2. Product Portfolio
      • 23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.7.4. SWOT Analysis
      • 23.3.7.5. Sales Footprint
      • 23.3.7.6. Strategy Overview
      • 23.3.7.7. Sales and Marketing strategies
      • 23.3.7.8. Channel Strategies
    • 23.3.8. MediCAD Hectec GmbH
      • 23.3.8.1. Overview & Key financials
      • 23.3.8.2. Product Portfolio
      • 23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.8.4. SWOT Analysis
      • 23.3.8.5. Sales Footprint
      • 23.3.8.6. Strategy Overview
      • 23.3.8.7. Sales and Marketing strategies
      • 23.3.8.8. Channel Strategies
    • 23.3.9. 3D Systems, Inc
      • 23.3.9.1. Overview & Key financials
      • 23.3.9.2. Product Portfolio
      • 23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.9.4. SWOT Analysis
      • 23.3.9.5. Sales Footprint
      • 23.3.9.6. Strategy Overview
      • 23.3.9.7. Sales and Marketing strategies
      • 23.3.9.8. Channel Strategies
    • 23.3.10. PEEK HEALTH S.A
      • 23.3.10.1. Overview & Key financials
      • 23.3.10.2. Product Portfolio
      • 23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.10.4. SWOT Analysis
      • 23.3.10.5. Sales Footprint
      • 23.3.10.6. Strategy Overview
      • 23.3.10.7. Sales and Marketing strategies
      • 23.3.10.8. Channel Strategies
    • 23.3.11. Radlink, Inc.
      • 23.3.11.1. Overview & Key financials
      • 23.3.11.2. Product Portfolio
      • 23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.11.4. SWOT Analysis
      • 23.3.11.5. Sales Footprint
      • 23.3.11.6. Strategy Overview
      • 23.3.11.7. Sales and Marketing strategies
      • 23.3.11.8. Channel Strategies
    • 23.3.12. SurgiNovi
      • 23.3.12.1. Overview & Key financials
      • 23.3.12.2. Product Portfolio
      • 23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.12.4. SWOT Analysis
      • 23.3.12.5. Sales Footprint
      • 23.3.12.6. Strategy Overview
      • 23.3.12.7. Sales and Marketing strategies
      • 23.3.12.8. Channel Strategies
    • 23.3.13. RSA Biomedical
      • 23.3.13.1. Overview & Key financials
      • 23.3.13.2. Product Portfolio
      • 23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.13.4. SWOT Analysis
      • 23.3.13.5. Sales Footprint
      • 23.3.13.6. Strategy Overview
      • 23.3.13.7. Sales and Marketing strategies
      • 23.3.13.8. Channel Strategies
    • 23.3.14. HIPOP-PLAN
      • 23.3.14.1. Overview & Key financials
      • 23.3.14.2. Product Portfolio
      • 23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.14.4. SWOT Analysis
      • 23.3.14.5. Sales Footprint
      • 23.3.14.6. Strategy Overview
      • 23.3.14.7. Sales and Marketing strategies
      • 23.3.14.8. Channel Strategies
    • 23.3.15. Zimmer Biomet.
      • 23.3.15.1. Overview & Key financials
      • 23.3.15.2. Product Portfolio
      • 23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.15.4. SWOT Analysis
      • 23.3.15.5. Sales Footprint
      • 23.3.15.6. Strategy Overview
      • 23.3.15.7. Sales and Marketing strategies
      • 23.3.15.8. Channel Strategies
    • 23.3.16. Optinav
      • 23.3.16.1. Overview & Key financials
      • 23.3.16.2. Product Portfolio
      • 23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.16.4. SWOT Analysis
      • 23.3.16.5. Sales Footprint
      • 23.3.16.6. Strategy Overview
      • 23.3.16.7. Sales and Marketing strategies
      • 23.3.16.8. Channel Strategies
    • 23.3.17. Enhatch Inc.
      • 23.3.17.1. Overview & Key financials
      • 23.3.17.2. Product Portfolio
      • 23.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.17.4. SWOT Analysis
      • 23.3.17.5. Sales Footprint
      • 23.3.17.6. Strategy Overview
      • 23.3.17.7. Sales and Marketing strategies
      • 23.3.17.8. Channel Strategies
    • 23.3.18. Numex GmbH
      • 23.3.18.1. Overview & Key financials
      • 23.3.18.2. Product Portfolio
      • 23.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.18.4. SWOT Analysis
      • 23.3.18.5. Sales Footprint
      • 23.3.18.6. Strategy Overview
      • 23.3.18.7. Sales and Marketing strategies
      • 23.3.18.8. Channel Strategies
    • 23.3.19. Corin Group
      • 23.3.19.1. Overview & Key financials
      • 23.3.19.2. Product Portfolio
      • 23.3.19.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.19.4. SWOT Analysis
      • 23.3.19.5. Sales Footprint
      • 23.3.19.6. Strategy Overview
      • 23.3.19.7. Sales and Marketing strategies
      • 23.3.19.8. Channel Strategies

24. Assumptions and Acronyms Used

25. Research Methodology